Bach JF, Rozanski EA, MacGregor J et al. (2006) Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. Journal of Veterinary Internal Medicine 20, 1132–1135

Brown AJ, Davison E and Sleeper MM (2010) Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs. Journal of Veterinary Internal Medicine 24, 850–854

Dias-Junior CA, Vieira TF, Moreno Jr H et al. (2005) Sildenafil selectively inhibits acute pulmonary embolism-induced pulmonary hypertension. Pulmonary Pharmacology and Therapeutics 18, 181–186

Kellihan HB and Stepien RL (2010) Pulmonary hypertension in dogs: diagnosis and therapy. Veterinary Clinics of North America: Small Animal Practice 40, 623–641

Nakamura K, Yamasaki M, Ohta H et al. (2011) Effects of sildenafil citrate on five dogs with Eisenmenger's syndrome. Journal of Small Animal Practice 52, 595–598

Novo-Matos J, Hurter K, Bektas R et al. (2014) Patent ductus arteriosus in an adult cat with pulmonary hypertension and right-sided congestive heart failure: hemodynamic evaluation and clinical outcome following ductal closure. Journal of Veterinary Cardiology 16, 197–203

Quintavalla F, Menozzi A, Pozzoli C et al. (2017) Sildenafil improves clinical signs and radiographic features in dogs with congenital idiopathic megaoesophagus: a randomised controlled trial. Veterinary Record 180, 404

Reinero C, Visser LC, Kellihan HB et al. (2020) ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs. Journal of Veterinary Internal Medicine 34, 549–573